<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Braxia Scientific Corp</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Tue, 21 Apr 2026 01:04:37 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>Braxia Scientific: Geschäftsmodell mit Zukunft</title>
<link>http://www.aktiencheck.de/forum/Braxia_Scientific_Geschaeftsmodell_mit_Zukunft-A3CPBM-t576260</link>
<guid>http://www.aktiencheck.de/forum/Braxia_Scientific_Geschaeftsmodell_mit_Zukunft-A3CPBM-t576260</guid>
<description>Die geben maximal Gas, haben sich zügig  einen Kreditrahmen bis zu 60 Mio. USD gesichert, von dem 40 Mio. schon fest zugesagt sind. Die haben die Übernahme wohl ganz, ganz fest im Visier.

https://money.tmx. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Braxia_Scientific_Geschaeftsmodell_mit_Zukunft-A3CPBM-t576260&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>Buy Braxia Scientific Before the Psychedelic Craze</title>
<link>http://www.aktiencheck.de/forum/Buy_Braxia_Scientific_Before_the_Psychedelic_Craze-A3CPBM-t576276</link>
<guid>http://www.aktiencheck.de/forum/Buy_Braxia_Scientific_Before_the_Psychedelic_Craze-A3CPBM-t576276</guid>
<description>Buy Braxia Scientific Before the Psychedelic Craze, Move over pot stocks, here comes the next group of “mind-bending” companies. Psychedelic stocks are picking up momentum after the FDA hinted at the approval of a brand-new treatment fad. Psilocybin, a naturally occurring psychedelic drug compound found most commonly in mushrooms, has been shown to help with depression, anxiety, OCD, PTSD, and even addiction.

And though it’s been used for many years, the FDA called psilocybin a “breakthrough therapy” for severe depression last year. Breakthrough therapy status is granted to new treatments by the FDA. In this case, it led to a US-based clinical trial with over 80 participants.

The results, according to the nonprofit Usona Institute, were very positive. Many experts believe it’s only a matter of time until full psilocybin approval is reached for medical use.

“As patents on many conventional antidepressants begin to expire – and public and regulatory opinion regarding psychedelic [&lt;a href=&#034;http://www.aktiencheck.de/forum/Buy_Braxia_Scientific_Before_the_Psychedelic_Craze-A3CPBM-t576276&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>Nach Cannabis folgen Mushrooms</title>
<link>http://www.aktiencheck.de/forum/Nach_Cannabis_folgen_Mushrooms-A3CPBM-t568348</link>
<guid>http://www.aktiencheck.de/forum/Nach_Cannabis_folgen_Mushrooms-A3CPBM-t568348</guid>
<description>News...., Jetzt müsste mal langsam Bewegung reinkommen und der Kurs nach Norden ziehen......

Braxia Scientific CEO und Chief Medical Officer erhält 918.000 US-Dollar von der kanadischen Regierung, um die Vorteile der Integration von Ketamin in eine kognitive Verhaltenstherapie zur Verringerung der Suizidalität zu untersuchen

https://www.canadianinsider. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Nach_Cannabis_folgen_Mushrooms-A3CPBM-t568348&#034;&gt;mehr&lt;/a&gt;]</description>
</item>



</channel>
</rss>







